Glaxosmithkline | Leverandørgæld



Trade Creditors Lave om Dato
AbbVie 2.94B 2.66B 2024-12
Amgen USD 2.41B 498M 2025-03
AstraZeneca 22.54B 79M 2025-03
Aurora Cannabis CAD 29.52M 20.78M 2024-12
Bausch Health Companies USD 620M 36M 2025-03
Bristol-Myers Squibb USD 4B 400M 2025-03
Canopy Growth CAD 28.92M 3.43M 2024-12
Corcept Therapeutics USD 15.38M 3.21M 2024-12
Drreddys Laboratories INR 36.02B 246M 2024-12
Eli Lilly USD 3.44B 213.4M 2025-03
GlaxoSmithKline 15.15B 186M 2025-03
Glaxosmithkline 3.46B 10.01B 2024-12
Indivior 183M 120M 2025-03
J&J USD 9.54B 766M 2025-03
Merck USD 3.78B 295M 2025-03
Novartis USD 4.57B 485M 2024-12
Pacira USD 19.13M 234K 2024-12
Perrigo USD 495.2M 36.7M 2024-12
Pfizer USD 5.24B 393M 2025-03
Prestige Brands USD 19.51M 11.67M 2024-12
Roche Holding 4.35B 828M 2024-12
Sanofi 21.62B 14.07B 2025-03
Supernus Pharmaceuticals USD 4.59M 1.8M 2024-12
Takeda JPY 460.18B 46.85B 2024-12
Teva Pharmaceutical Industries USD 2.2B 168M 2024-12
Zoetis USD 420M 13M 2025-03



Glaxosmithkline Leverandørgæld - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2025.